VAERS ID: 2156142

AGE: 10| SEX: M|State: FR

Description

Asthenia; General malaise; Pallor; Feeling of heat; Blurred vision; Lipothymia; Faintness; Fatigue; This is a spontaneous report received from a contactable reporter(s) (Physician) from the Regulatory authority -WEB. Regulatory number: FR-AFSSAPS-AM20220374. A 10 year-old male patient received bnt162b2 (COMIRNATY), intramuscular, administration date 09Jan2022 16:20 (Lot number: FN4072) at the age of 10 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ASTHENIA (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Asthenia"; MALAISE (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "General malaise"; PALLOR (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Pallor"; FEELING HOT (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Feeling of heat"; VISION BLURRED (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Blurred vision"; PRESYNCOPE (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Lipothymia"; DIZZINESS (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Faintness"; FATIGUE (hospitalization) with onset 09Jan2022, outcome "recovered" (09Jan2022), described as "Fatigue". There was no loss of urine, he had eaten well for lunch. Kept at the vaccination center with infusion and given sugar but persistence of significant asthenia with impossibility to stand up. The patient was hospitalized for asthenia, malaise, pallor, feeling hot, vision blurred, presyncope, dizziness, fatigue (Hospitalized for monitoring with favorable evolution and discharge authorized the next morning. Hospitalization duration: 1 day(s)). The patient underwent the following laboratory tests and procedures: blood glucose: normal; blood pressure measurement: normal; electrocardiogram: normal; heart rate: normal; oxygen saturation: 100 %. Therapeutic measures were taken as a result of asthenia, malaise, pallor, feeling hot, vision blurred, presyncope, dizziness, fatigue. No follow-up attempts are possible. No further information is expected.

Symptoms

Asthenia, Fatigue, Pallor, Blood glucose, Feeling hot, Presyncope, Blood pressure measurement, Heart rate, Vision blurred, Dizziness, Malaise, Electrocardiogram, Oxygen saturation

Vaccines

VAX DATE: 08 January 2022 | ONSET DATE: 08 January 2022 | DAYS TO ONSET: 0
Vaccine TypeManufacturerVaccine NameDoseRouteSiteLot
  • COVID19
  • PFIZERBIONTECH
  • COVID19 (COVID19 (PFIZER-BIONTECH))
        RECVDATE:
        03 March 2022
        CAGE_YR:
        CAGE_MO:
        RPT_DATE:
        DIED:
        DATEDIED:
        L_THREAT:
        ER_VISIT:
        HOSPITAL:
        Y
        HOSPDAYS:
        1
        X_STAY:
        DISABLE:
        RECOVD:
        Y
        LAB_DATA:
        Test Name: blood glucose; Result Unstructured Data: Test Result:normal; Test Name: blood pressure; Result Unstructured Data: Test Result:normal; Test Name: ECG; Result Unstructured Data: Test Result:normal; Test Name: heart rate; Result Unstructured Data: Test Result:normal; Test Name: SpO2; Test Result: 100 %
        V_ADMINBY:
        OTH
        OTHER_MEDS:
        CUR_ILL:
        HISTORY:
        PRIOR_VAX:
        SPLTTYPE:
        FRPFIZER INC202200293918
        FORM_VERS:
        2
        TODAYS_DATE:
        01 March 2022
        BIRTH_DEFECT:
        OFC_VISIT:
        ER_ED_VISIT:
        ALLERGIES:
        V_FUNDBY: